SCHEMBL1879320

SCHEMBL1879320

COC(=O)C=Cc1ccc(OC)c(OC)c1OC

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 1/20 0.69
CYP1A1 P04798 4/20 0.61
CYP1B1 Q16678 4/20 0.61
CYP1A2 P05177 2/20 0.61
CYP2D6 P10635 2/20 0.61
NPC1 O15118 1/20 0.59
LMNA P02545 1/20 0.59
TP53 P04637 1/20 0.59
RAB9A P51151 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
NFE2L2 Q16236 2/20 0.56
CHRNA7 P36544 1/20 0.56
CYP3A4 P08684 1/20 0.56
MAPT P10636 1/20 0.50
CYP19A1 P11511 1/20 0.50
FDPS P14324 1/20 0.49
EPHX2 P34913 1/20 0.49
ALOX5 P09917 1/20 0.48
ABCB1 P08183 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1879319 1.00 ABCG2 (0.69) ABCG2CYP1A1CYP1B1CYP1A2CYP2D6
SCHEMBL1878036 0.87 ABCG2 (0.54) ABCG2CYP1A1CYP1B1CYP1A2CYP2D6
SCHEMBL1878033 0.87 ABCG2 (0.54) ABCG2CYP1A1CYP1B1CYP1A2CYP2D6
SCHEMBL20586547 0.87 NFE2L2 (0.74) ABCG2CYP1A1CYP1B1CYP1A2CYP2D6
SCHEMBL2743991 0.86 ABCG2 (0.73) ABCG2CYP1A1CYP1B1CYP1A2CYP2D6
SCHEMBL2744097 0.86 ABCG2 (0.73) ABCG2CYP1A1CYP1B1CYP1A2CYP2D6
SCHEMBL7438631 0.85 NFE2L2 (0.77) CYP1A1CYP1A2CYP2D6NPC1LMNA
SCHEMBL7438622 0.85 NFE2L2 (0.77) CYP1A1CYP1A2CYP2D6NPC1LMNA
SCHEMBL285232 0.85 ABCG2 (0.71) ABCG2CYP1A1CYP1B1CYP1A2CYP2D6
SCHEMBL1881561 0.85 ABCG2 (0.71) ABCG2CYP1A1CYP1B1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117062533-A Edible barrier film compositions 阿比尔技术公司 2023-11-14 CN disclosed
EP-1666440-B1 METHOD FOR PRODUCING AROMATIC UNSATURATED COMPOUND SUMITOMO CHEMICAL CO (JP) 2014-01-22 EP disclosed
US-7939674-B2 Process for producing an aromatic unsaturated compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-05-10 US disclosed
US-7700642-B2 Process for producing an aromatic unsaturated compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-20 US disclosed
US-20090111999-A1 PROCESS FOR PRODUCING AN AROMATIC UNSATURATED COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-04-30 US disclosed
US-20080221337-A1 Process for Producing an Aromatic Unsaturated Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-09-11 US disclosed
EP-1666440-A1 METHOD FOR PRODUCING AROMATIC UNSATURATED COMPOUND Sumitomo Chemical Company, Limited (JP) 2006-06-07 EP disclosed
US-5426210-A Water soluble sunscreen agents SHISEIDO CO., LTD. (JP) 1995-06-20 US disclosed
EP-0539601-A1 CINNAMIC ACID/GLYCEROL ADDUCT, ULTRAVIOLET ABSORBER, AND DERMATOLOGIC PREPARATION SHISEIDO COMPANY LIMITED (JP) 1993-05-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221337-A1 Process for Producing an Aromatic Unsaturated Compound AHR, AR, ARSA ABCG2 1037/4885CYP1A1 4/4885CYP1B1 13/4885
US-20090111999-A1 PROCESS FOR PRODUCING AN AROMATIC UNSATURATED COMPOUND AHR, AR, ARSA ABCG2 1037/4885CYP1A1 4/4885CYP1B1 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.